Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 312-322 |
| Seitenumfang | 11 |
| Fachzeitschrift | Cancer investigation |
| Jahrgang | 28 |
| Ausgabenummer | 3 |
| Frühes Online-Datum | 28 Okt. 2009 |
| Publikationsstatus | Veröffentlicht - 2010 |
Abstract
Aim of this paper is to review and describe Health-Related Quality of Life (HRQoL) measures applied in kidney cancer, hepatocellular carcinoma, and leukemia patients under drug therapy. A comprehensive search in PubMed was conducted to identify studies assessing quality of life (QoL) in these indications. In total 32 studies, including four studies through reference list checking and 21 different HRQoL instruments, were identified. Six generic, five disease-specific, and 10 domain-specific instruments were identified. In conclusion no overall standards in HRQoL measurement could be observed in the respective indications.
ASJC Scopus Sachgebiete
- Medizin (insg.)
- Onkologie
- Biochemie, Genetik und Molekularbiologie (insg.)
- Krebsforschung
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Cancer investigation, Jahrgang 28, Nr. 3, 2010, S. 312-322.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - A Structured Review and Guide Through Studies on Health-Related Quality of Life in Kidney Cancer, Hepatocellular Carcinoma, and Leukemia
AU - Liu, Jia
AU - Mittendorf, Thomas
AU - Von Der Schulenburg, J. Matthias
PY - 2010
Y1 - 2010
N2 - Aim of this paper is to review and describe Health-Related Quality of Life (HRQoL) measures applied in kidney cancer, hepatocellular carcinoma, and leukemia patients under drug therapy. A comprehensive search in PubMed was conducted to identify studies assessing quality of life (QoL) in these indications. In total 32 studies, including four studies through reference list checking and 21 different HRQoL instruments, were identified. Six generic, five disease-specific, and 10 domain-specific instruments were identified. In conclusion no overall standards in HRQoL measurement could be observed in the respective indications.
AB - Aim of this paper is to review and describe Health-Related Quality of Life (HRQoL) measures applied in kidney cancer, hepatocellular carcinoma, and leukemia patients under drug therapy. A comprehensive search in PubMed was conducted to identify studies assessing quality of life (QoL) in these indications. In total 32 studies, including four studies through reference list checking and 21 different HRQoL instruments, were identified. Six generic, five disease-specific, and 10 domain-specific instruments were identified. In conclusion no overall standards in HRQoL measurement could be observed in the respective indications.
KW - Health-related quality of life
KW - Hepatocellular carcinoma
KW - Kidney cancer
KW - Leukemia
KW - Patient-reported outcome
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=77149137763&partnerID=8YFLogxK
U2 - 10.3109/07357900903287022
DO - 10.3109/07357900903287022
M3 - Article
C2 - 19863345
AN - SCOPUS:77149137763
VL - 28
SP - 312
EP - 322
JO - Cancer investigation
JF - Cancer investigation
SN - 0735-7907
IS - 3
ER -